- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01712282
Physical Activity Immediately After Acute Cerebral Ischemia 3
Physical Activity Immediately After Acute Cerebral Ischemia: Too Little or Too Much
Stroke is the leading cause of adult disability in Europe and United States and the second leading cause of death worldwide and affects more than 10,000 Danes each year.
Studies in a late and stationary phase after stroke have shown that physical rehabilitation is of great importance for survival and physical ability of these patients, however many studies show that patients lie or sit next to their bed under hospitalization for more than 88.5 % of the daily hours. Physical activity in stroke patients has never previously been measured immediately after debut of symptoms; furthermore there is no knowledge about the optimal dose of physical rehabilitation for these patients.
Accelerometers, small measuring devices, are a relatively new way to measure physical activity precisely, and hence it is possible to obtain an objective measure of how active stroke patients are in the first week after admission. The accelerometers measure a variable voltage, depending on the range and intensity of movement. They can measure movement dependent of the placement of the accelerometer, for instance over the hip, arm or leg. Studies confirm their reliability, even in patients with abnormal gait, such as stroke patients.
Another approach of studying the effects of physical activity and rehabilitation is through the examination of biomarkers. Studies have shown that biomarkers released during physical activity can inhibit biomarkers released after tissue injury in the brain, as seen after stroke. These brain biomarkers cause further damage and studies show that the higher the levels, the higher the damage. It is therefore obvious to examine whether physical activity rehabilitation can down regulate this destructive process in patients with stroke.
Clarification of the optimal dose of physical activity in stroke patients immediately after debut of symptoms and examination of both the biochemical aspects of physical rehabilitation as well as the optimal dose of physical rehabilitation is of great importance for many patients, their relatives as well as of a great socioeconomic importance.
The purpose of the project is to investigate feasibility of treadmill training on a weight-bearing treadmill in the acute phase after admission after an ischemic stroke. Furthermore we wish to investigate the acute inflammatory response after ischemic stroke and whether it changes with treadmill training.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Anna M Strømmen, MD
- Telefonnummer: +4548297353
- E-mail: anna.maria.stroemmen@regionh.dk
Studiesteder
-
-
-
Hillerød, Danmark, 3400
- Rekruttering
- Hillerød Hospital
-
Kontakt:
- Anna Maria Strømmen, MD
- Telefonnummer: +4548297353
- E-mail: anna.maria.stroemmen@regionh.dk
-
Ledende efterforsker:
- Anna Maria Strømmen, MD
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- patients admitted with acute ischemic stroke
- age > 18 years
- first stroke or only minor invalidity from previous strokes (mRS 0-2)
- truncal stability
- SSS score for arm and leg: 10 out of 12 points
Exclusion Criteria:
- symptoms attributable to other diseases than ischemic stroke
- debut of symptoms > 48 h prior to admission
- consent not given < 24 h of admission
- pregnancy or lactation
- isolation
- blood sampling generally not possible
- allergy due to accelerometer wear
- ulcers or other skin diseases in the area of accelerometer placement
- unstable cardiologic condition (AMI etc.)
- acute high and sustained resting systolic blood pressure where treatment is necessary
- acute heart rhythm disorder where treatment is necessary
- unable to cooperate
- significant orthopedic conditions (fractures etc.)
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Tildeling: Ikke-randomiseret
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: High dose training
2 x 30 minutes/day on a weight-bearing treadmill
|
weight-bearing treadmill, pulse reserve increase of 50%
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Level of inflammation, under, during and after treadmill training
Tidsramme: up to 5 days
|
Biomarker concentration: Interleukin (IL)-6, IL-1beta, Tumor Necrosis Factor(TNF)-alpha, C-Reactive Protein (CRP), IL-1ra, IL-10, fasting-insulin, fasting-glucose
|
up to 5 days
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Correlation of biomarker level
Tidsramme: up to 5 days
|
Correlation with time, activity counts on an accelerometer, Scandinavian Stroke Scale Score (SSS), National Institutes of Health Stroke Scale score (NIHSS), Glasgow Coma Scale (GCS), Barthels Index-100 (BI), 10 Meters Walking Test (10MWT), modified Rankin Scale (mRS), Assessment of Motor and Process Skills (AMPS), Bergs Balance test, age, Body Mass Index and sex
|
up to 5 days
|
Feasibility
Tidsramme: up to 5 days
|
Whether it is feasible/possible to train patients on a treadmill in the acute phase after ischemic stroke; eg.
whether patients are too exhausted to train twice daily, experience complications during training such as nausea or dizziness and therefore can't complete the training programme.
|
up to 5 days
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 30704 part 3
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med physical activity, 2 x 30 minutes/day
-
Istanbul University - Cerrahpasa (IUC)Ikke rekrutterer endnu
-
Yasin AkAfsluttetStillesiddende tid | Stillesiddende adfærdKalkun
-
Universiteit AntwerpenUniversity Hospital, Antwerp; Cliniques universitaires Saint-Luc- Université...Rekruttering
-
PfizerAfsluttetLændesmerterChile, Venezuela, Ecuador, Colombia, Brasilien, Mexico, Argentina, Peru, Costa Rica
-
Alexza Pharmaceuticals, Inc.Atlanta Center for Medical ResearchAfsluttetFrivillige på kroniske, stabile antipsykotiske regimerForenede Stater
-
ExCellThera inc.Memorial Sloan Kettering Cancer CenterRekrutteringNavlestrengsblodtransplantation | Højrisiko Myeloid MaligniteterForenede Stater
-
National Cancer Institute (NCI)AfsluttetKronisk lymfatisk leukæmiForenede Stater
-
Fundación Leucemia y Linfoma, SpainRoche Pharma AGAfsluttetNon-Hodgkins lymfomSpanien
-
Children's Oncology GroupNational Cancer Institute (NCI); EsPhALL Network/ BFM Study GroupRekrutteringAkut lymfatisk leukæmi | B Akut lymfatisk leukæmi | T Akut lymfatisk leukæmi | Blandet fænotype akut leukæmiForenede Stater, Canada, Puerto Rico, Australien, Finland, New Zealand, Saudi Arabien, Tyskland, Østrig, Belgien, Chile, Tjekkiet, Frankrig, Italien, Holland, Sverige, Schweiz, Hong Kong, Israel